Abstract
BackgroundNucleic acid amplification (NAAT) testing for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) is now widely available but not licensed for use at non-genital sites. Despite this, high rates of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
